Skip to main content
. 2012 May;46(5):582–591. doi: 10.1165/rcmb.2011-0296OC

Figure 6.

Figure 6.

The reopening of small vessels and the reduction of pulmonary hypertension by tetrathiomolybdate (TTM) is associated with reduced cleaved caspase-3 expression (A), and cannot be prevented by concurrent treatment with the pan-caspase inhibitor Z-Asp (B), which suggests that the induction of cell-death by TTM is caspase-independent.